Table 2.
Effect of the novel furanylnicotinamidine derivatives on Gram-negative and Gram-positive microorganisms
| 100 µM- (µg/mL) | Gram-negative
|
Gram-positive
|
||
|---|---|---|---|---|
| Escherichia coli | Pseudomonas aeruginosa | Staphylococcus aureus | Bacillus megaterium | |
| 4a- (33.62) | 14 | 12 | 12 | 14 |
| 4b- (37.98) | 13 | 11 | 11 | 13 |
| 4c- (41.43) | 12 | 11 | 12 | 14 |
| 3d- (28.93) | 6 | 4 | 4 | 5 |
| 4d- (44.28) | 12 | 11 | 11 | 13 |
| 4e- (37.07) | 13 | 11 | 12 | 13 |
| 4f- (36.32) | 10 | 12 | 10 | 10 |
| 4g- (41.86) | 13 | 12 | 12 | 13 |
| 4h- (38.12) | 11 | 11 | 12 | 12 |
| 4i- (38.12) | 11 | 10 | 9 | 10 |
| Ampicillin-(34.94) | 17 | 14 | 13 | 16 |
Note: The results expressed as zone inhibition in mm diameter.